Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Disease Cell Type Therapeutic or Technology Institution Stage Project Objective Details
Cartilage defect Embryonic Stem Cell Donor cell therapy USC
IND
Blood Cancer Adult Stem Cell Gene-modified, personalized cell therapy UCSD
IND
Muscular Dystrophy Embryonic Stem Cell Protein/peptide therapy Juvena Therapeutics Inc
Pre-IND/IDE or Equivalent
Stroke iPS Cell Donor cell therapy UCLA
Pre-IND/IDE or Equivalent
Heart Disease Adult Stem Cell Antibody UCLA
Pre-IND/IDE or Equivalent
IPEX Syndrome Adult Stem Cell Gene-modified, personalized cell therapy ImmunoVec
Pre-IND/IDE or Equivalent
Brain Cancer Somatic Cell Gene-modified, personalized cell therapy UCSF
Pre-IND/IDE or Equivalent
Heart Disease iPS Cell Protein/peptide therapy Regencor, Inc.
Pre-IND/IDE or Equivalent
Metabolic Disorders Somatic Cell Gene-modified, personalized cell therapy Immusoft Corporation
Pre-IND/IDE or Equivalent
Duchenne Muscular Dystrophy Somatic Cell Gene Therapy, cell free MyoGene Bio LLC
Pre-IND/IDE or Equivalent
B cell cancers Somatic Cell Gene-modified, personalized cell therapy UCSF
Pre-IND/IDE or Equivalent
Spinal Cord Injury Adult Stem Cell Donor cell therapy UC Irvine
Pre-IND/IDE or Equivalent
Heart Disease iPS Cell Model system development Organos Inc.
Tool/Resources/Bottleneck
Heart failure Adult Stem Cell Nucleic acid based therapy Cedars-Sinai
Development Candidate, Proof of Concept
Neurological Disorders iPS Cell Gene Therapy, cell free Navega Therapeutics
Development Candidate, Proof of Concept
Spinal Cord Injury iPS Cell Donor cell therapy Stanford
Development Candidate, Proof of Concept
Multiple Myeloma Somatic Cell Gene-modified, personalized cell therapy UCSF
Development Candidate, Proof of Concept
Multiple Sclerosis Adult Stem Cell Small molecule therapy Scripps
Development Candidate, Proof of Concept
Kidney Disease Somatic Cell Gene Therapy, cell free UCSF
Development Candidate, Proof of Concept
Neurological Disorders,
Sanfilippo Syndrome/MPS III
iPS Cell Gene-modified, personalized cell therapy UC Irvine
Development Candidate, Proof of Concept
Huntington's Disease iPS Cell Gene Therapy, cell free UCSD
Development Candidate, Proof of Concept
Cartilage defect Adult Stem Cell Biologic The Stone Research Foundation for Sports Medicine and Arthritis
Development Candidate, Proof of Concept
Cartilage defect,
Osteoarthritis
Embryonic Stem Cell Donor cell therapy Scripps Health
Development Candidate, Proof of Concept
Type 1 diabetes iPS Cell Biologic UCLA
Development Candidate, Proof of Concept
Muscle Injury Adult Stem Cell Personalized cell therapy UCSF
Development Candidate, Proof of Concept
Skeletal/Smooth Muscle disorders Embryonic Stem Cell,
iPS Cell
Exosomes based therapy Stanford
Development Candidate, Proof of Concept
Sarcoma Adult Stem Cell Gene-modified, personalized cell therapy Stanford
Development Candidate, Proof of Concept
Type 1 diabetes Embryonic Stem Cell Gene-modified, donor cell therapy Salk
Development Candidate, Proof of Concept
Breast Cancer Adult Stem Cell Gene-modified, donor cell therapy Cytonus Therapeutics, Inc.
Development Candidate, Proof of Concept
Other Adult Stem Cell Protein/peptide therapy Intact Therapeutics, Inc.
Development Candidate, Proof of Concept
Immune Disease,
Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID)
Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Clinical Trial, Phase 2
IPEX Syndrome Adult Stem Cell Gene-modified, personalized cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
Wounds, ulcers Small molecule therapy UCLA
IND
Solid Tumors Adult Stem Cell Personalized cell therapy BioEclipse Therapeutics INC.
Clinical Trial, Phase 1 or Phase 1/2
Retinitis Pigmentosa Somatic Cell Gene Therapy, cell free Ray Therapeutics, INC
Pre-IND/IDE or Equivalent
Hypertension, pulmonary arterial Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Pre-IND/IDE or Equivalent
Prostate Cancer Gene-modified, personalized cell therapy USC
Pre-IND/IDE or Equivalent
Kidney Failure Adult Stem Cell Device UC Davis
Pre-IND/IDE or Equivalent
Muscle Injury Adult Stem Cell Personalized cell therapy UC Davis
Clinical Trial, Phase 1 or Phase 1/2
Epilepsy Embryonic Stem Cell Donor cell therapy Neurona Therapeutics
Clinical Trial, Phase 1 or Phase 1/2
Tenaya Therapeutics, Inc.
Stanford
UCLA
Blood Disorders Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Development Candidate, Proof of Concept
UC Davis
Scripps
Intestinal Disease iPS Cell Exploring disease mechanisms Cedars-Sinai
Proof of Concept, Tool/Resources/Bottleneck
UCSD
UCLA
Alzheimer's Disease,
Parkinson's Disease
iPS Cell Small molecule therapy Scripps
Development Candidate, Proof of Concept

Pages

Icon for csv export